Iodide

Iodide

SCHEMBL1720530

Cc1[nH]c(=O)c2ccccc2c1C[N+](C)(C)C.[I-]

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG

The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.41
CHRM2 P08172 1/20 0.40
CHRNA7 P36544 1/20 0.40
ALDH1A1 P00352 5/20 0.39
PARP1 P09874 7/20 0.39
KDM4E B2RXH2 3/20 0.39
TNKS2 Q9H2K2 2/20 0.39
MEN1 O00255 1/20 0.39
TNKS O95271 1/20 0.39
LMNA P02545 1/20 0.39
CYP1A2 P05177 1/20 0.39
GPR3 P46089 1/20 0.39
BLM P54132 1/20 0.39
PMP22 Q01453 1/20 0.39
KMT2A Q03164 1/20 0.39
PARP15 Q460N3 1/20 0.39
HSD17B10 Q99714 1/20 0.39
GAA P10253 3/20 0.39
MAPT P10636 2/20 0.37
CASP1 P29466 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13901581 0.98 HTT (0.42) HTTCHRM2CHRNA7ALDH1A1PARP1
Iodide SCHEMBL1720349 0.81 TNKS2 (0.40) HTTCHRM2CHRNA7ALDH1A1PARP1
Iodide SCHEMBL1720068 0.80 PARP1 (0.46) ALDH1A1PARP1KDM4EMEN1LMNA
Iodide SCHEMBL1721148 0.80 PARP1 (0.41) PARP1
Iodide SCHEMBL1720544 0.80 CHRNA7 (0.40) CHRM2CHRNA7ALDH1A1PARP1KDM4E
SCHEMBL1720937 0.79 TNKS2 (0.41) HTTCHRM2CHRNA7ALDH1A1PARP1
SCHEMBL1720998 0.78 PARP1 (0.42) PARP1
SCHEMBL13901568 0.78 PARP1 (0.47) ALDH1A1PARP1KDM4EMEN1LMNA
SCHEMBL13901566 0.78 CHRM2 (0.38) CHRM2CHRNA7ALDH1A1PARP1KDM4E
SCHEMBL1720604 0.76 MAPT (0.64) HTTALDH1A1PARP1KDM4ETNKS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1566380-B1 ISOQUINOLINE COMPOUNDS AND MEDICINAL USE THEREOF MITSUBISHI TANABE PHARMA CORP (JP) 2012-01-11 EP disclosed
US-7501412-B2 Isoquinoline compounds and medicinal use thereof MITSUBISHI TANABE PHARMA CORPORATION (JP) 2009-03-10 US disclosed
US-20060094743-A1 Isoquinoline compounds and medicinal use thereof MITSUBISHI PHARMA CORPORATION (JP) 2006-05-04 US disclosed
EP-1566380-A1 ISOQUINOLINE COMPOUNDS AND MEDICINAL USE THEREOF Mitsubishi Pharma Corporation (JP) 2005-08-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060094743-A1 Isoquinoline compounds and medicinal use thereof PARP1, NQO1, PARP3 HTT 911/4885CHRM2 4443/4885CHRNA7 2196/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.